Recent Quotes (30 days)

You have no recent quotes
chg | %

IMRIS Inc  

(Public, TSE:IM)   Watch this stock  
Find more results for IM
2.77
+0.02 (0.73%)
May 17 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 2.77 - 2.77
52 week 2.70 - 4.68
Open 2.77
Vol / Avg. 200.00/20,527.00
Mkt cap 127.50M
P/E     -
Div/yield     -
EPS -0.58
Shares 46.03M
Beta 1.35
Inst. own 12%
Aug 5, 2013
Q2 2013 IMRIS INC Earnings Release Add to calendar
May 13, 2013
Q1 2013 IMRIS INC Earnings Release
May 2, 2013
IMRIS INC Annual Shareholder Meeting
May 2, 2013
Q1 2013 IMRIS INC Earnings Conference Call
Mar 5, 2013
Q4 2012 IMRIS INC Earnings Conference Call
  

Key stats and ratios

Q3 (Sep '12) 2011
Net profit margin -73.65% -40.40%
Operating margin -74.25% -39.70%
EBITD margin - -32.92%
Return on average assets -38.74% -19.97%
Return on average equity -56.43% -24.94%
Employees 169 -
Carbon Disclosure Rating - -

Address

100, 1370 Sony Place
WINNIPEG, MB R3T 1N5
Canada
+1-204-4807070 (Phone)
+1-204-4807071 (Fax)

Website links

External links

Discussion Group - Google Finance

Description

IMRIS Inc. (IMRIS) designs, manufactures and markets the VISIUS Surgical Theatre, a multifunctional surgical environment that provides intraoperative vision to clinicians. Designed to enable hospital�s clinical application needs, the VISIUS Surgical Theatre can incorporate magnetic resonance (MR) imaging, computed tomography (CT) imaging and x-ray angiography in a number of configurations to provide intraoperative images of diagnostic quality. IMRIS sells the VISIUS Surgical Theatres globally to hospitals that deliver clinical services to patients in the neurosurgical, cerebrovascular and cardiovascular markets. The VISIUS Surgical Theatre incorporates magnetic resonance imaging, CT and fluoroscopy into multi-purpose surgical suites to provide truly intra-operative imaging for specific medical applications.

Officers and directors

H. David Graves Chairman of the Board, Chief Executive Officer
Jay D. Miller President, Chief Operating Officer
Age: 52
Kelly B. McNeill Chief Financial Officer, Executive Vice President - Finance & Administration, Secretary
Mark Reade Executive Vice President - Global Sales
Amy Boyle Executive Vice President - Marketing
Denis Sutton Executive Vice President - Human Resources
Pablo Batista Executive Vice President - Operations
Meir Dahan Executive Vice President - Research and Development
Robert K. Burgess Independent Director
Age: 55
Robert Courteau Independent Director